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Abstract
Background: The Mycobacterium tuberculosis complex (MTC) comprises closely related species responsible for strictly
human and zoonotic tuberculosis. Accurate species determination is useful for the identification of outbreaks and
epidemiological links. Mycobacterium africanum and Mycobacterium canettii are typically restricted to Africa and M. bovis is a
re-emerging pathogen. Identification of these species is difficult and expensive.
Methodology/Principal Findings: The Exact Tandem Repeat D (ETR-D; alias Mycobacterial Interspersed Repetitive Unit 4)
was sequenced in MTC species type strains and 110 clinical isolates, in parallel to reference polyphasic identification based
on phenotype profiling and sequencing of pncA, oxyR, hsp65, gyrB genes and the major polymorphism tandem repeat.
Inclusion of M. tuberculosis isolates in the expanding, antibiotic-resistant Beijing clone was determined by Rv0927c gene
sequencing. The ETR-D (780-bp) sequence unambiguously identified MTC species type strain except M. pinnipedii and M.
microti thanks to six single nucleotide polymorphisms, variable numbers (1–7 copies) of the tandem repeat and two
deletions/insertions. The ETR-D sequencing agreed with phenotypic identification in 107/110 clinical isolates and with
reference polyphasic molecular identification in all isolates, comprising 98 M. tuberculosis,5M. bovis BCG type, 5 M. canettii,
and 2 M. africanum. For M. tuberculosis isolates, the ETR-D sequence was not significantly associated with the Beijing clone.
Conclusions/Significance: ETR-D sequencing allowed accurate, single-step identification of the MTC at the species level. It
circumvented the current expensive, time-consuming polyphasic approach. It could be used to depict epidemiology of
zoonotic and human tuberculosis, especially in African countries where several MTC species are emerging.
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The Mycobacterium tuberculosis complex (MTC) comprises several
closely related species responsible for strictly human and zoonotic
tuberculosis (Figure 1). In addition to M. tuberculosis, which
represents the leading cause of human tuberculosis worldwide and
is now emerging as extensively drug-resistant tuberculosis strains
[1], other MTC species have been found in patients, typically in
African countries (Figure 2). Mycobacterium bovis is a re-emerging,
zoonotic agent of bovine tuberculosis [2] whose prevalence
probably depends on variations in direct exposure to cattle and
consumptionof unpasteurised dairy products [3]. The prevalenceof
Mycobacterium africanum type I (West Africa) and type II (East Africa)
[4] has decreased in several African countries over the last decades
[5,6]. Mycobacterium canettii, a rare MTC species, has been isolated
recently inpatientsexposedinAfrica[7]. Mycobacteriummicroti,a vole
and small rodent pathogen [8] that is closely related to the so-called
Dassie-bacillus and infects small mammals in South Africa and the
Middle East [9,10], has been isolated in humans [11]. Mycobacterium
caprae is a rare cause of tuberculosis in cattle [12,13] and zoonotic
tuberculosis in humans [14] while Mycobacterium pinnipedii has been
isolated from seal lions and fur seals [15]. A recent descriptionof the
re-emergence of M. bovis in cattle, along with the direct interhuman
transmission of this zoonotic organism [16] in a six-case cluster that
included one death inUnitedKingdom [17],illustratesthepotential
of emerging and re-emerging zoonotic tuberculosis due to MTC
species other than M. tuberculosis and the necessity for accurate
species identification.
Accurate species identification of all MTC members is
warranted in order to distinguish between strict human and
zoonotic tuberculosis and to trace source exposure during
epidemiological studies. Indeed, phenotypic methods of identifi-
cation relying on colony morphology, oxygen preference, niacin
accumulation, nitrate reductase activity, growth kinetics and
resistance to thiophene-2-carboxylic acid hydrazide (TCH) and
PZA [18] are hampered by slow growth of MTC members and
subjective interpretation of colony morphology and cross-resis-
tance to drugs [19]. They do not always allow unambiguous
species identification in every case. Recent studies of MTC species
responsible for animal and human tuberculosis in tropical
countries have relied on molecular methods including mycobac-
terial interspersed repetitive-unit-variable-number tandem-repeat
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Molecular differentiation of MTC members has been complicated
by low sequence variability at the nucleotide level, illustrated by a
85–100% DNA/DNA relatedness and a 99–100% 16S rDNA
sequence similarity [23,24]. Nucleic acid-based assays such as
acridinium ester-labelled DNA probes (AccuProbe; Gene Probe
Inc, San Diego, CA) have proven to be reliable tools for assigning
an isolate to the MTC [25,26], but they do not allow for
identification at the species level. Molecular identification based on
deleted regions (RD), RD1, RD9 and RD10 [27], are limited by
the necessity of interpreting negative results in the case of the
absence of a specific deletion. The detection of single nucleotide
polymorphisms (SNP) in the pncA gene [28], the oxyR locus [29],
the mtp40 gene [30], and the restriction fragment length
polymorphism of the hupB gene [31] differentiated M. tuberculosis
from M. bovis but not from other MTC species. The major
polymorphism of tandem repeat (MPTR) sequencing differentiat-
ed M. tuberculosis (Sequevar long), M. bovis and M. microti (Sequevar
Med-G), M. bovis BCG (Sequevar Med-C) and M. africanum
(Sequevar short), but other MTC species were not studied [32].
The gyrB gene proved to be an effective target [33,34], as an
identification scheme has been proposed based on Pyrosequencing
analysis of four single nucleotide polymorphism (SNPs) in gyrB
[35], and a DNA strip based on gyrB is commercially available
(HAIN Genotype MTBC DNAstrip test, Hain Lifescience,
Nehren, Germany) [36]. Both approaches, however, fail to
differentiate M. tuberculosis from M. africanum type II and M.
canettii; and M. africanum type I from M. pinnipedii.I S 6110-RFLP,
VNTR typing and Spoligotyping [22,37] emerged as reference
methods to study the diversity of MTC species in resource-limited
countries, despite the fact that these methods may not recognize
rarely encountered species and may not appreciate the entire
genetic diversity of strains, as they are not based upon the
sequencing of molecular targets [38].
When investigating intergenic spacers in the genotyping of M.
tuberculosis, we found that one spacer, previously identified as the
Exact Tandem Repeat D (ETR-D) [39] and aliased Mycobacterial
Interspersed Repeat Unit 04 (MIRU04) [40], exhibited a variable
sequence among M. tuberculosis isolates. Analysis of this spacer had
been previously shown to distinguish between M. bovis and the M.
bovis BCG type [41]. We therefore further investigated whether
sequencing the ETR-D could identify all of the MTC at the
species level. In this study, we demonstrate that ETR-D
sequencing offers a new tool for the rapid and accurate
identification of MTC species in a single reaction.
Figure 1. Distribution of rare Mycobacterium tuberculosis complex species in humans (filled circles) and animals (open circles). Green
circles, M. canettii; blue circles, M. caprae; pink circles, M. microti; orange circles, M. pinnipedii.
doi:10.1371/journal.pntd.0000253.g001
Author Summary
The Mycobacterium tuberculosis complex (MTC) comprises
several closely related species responsible for strictly
human and zoonotic tuberculosis. Some of the species
are restricted to Africa and were responsible for the high
prevalence of tuberculosis. However, their identification at
species level is difficult and expansive. Accurate species
identification of all members is warranted in order to
distinguish between strict human and zoonotic tubercu-
losis, to trace source exposure during epidemiological
studies, and for the appropriate treatment of patients. In
this paper, the Exact Tandem Repeat D (ETR-D) intergenic
region was investigated in order to distinguish MTC
species. The ETR-D sequencing unambiguously identified
MTC species type strain except M. pinnipedii and M.
microti, and the results agreed with phenotypic and
molecular identification. This finding offers a new tool for
the rapid and accurate identification of MTC species in a
single sequencing reaction, replacing the current time-
consuming polyphasic approach. Its use could assist public
health interventions and aid in the control of zoonotic
transmission in African countries, and could be of
particular interest with the current emergence of multi-
drug-resistant and extended-resistance isolates.
MTC Identification
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Bacterial isolates
M. tuberculosis CIP103471, M. bovis CIP105050, M. africanum
CIP105147
T (type I), M. bovis BCG vaccine strain type 105060, M.
microti CIP104256
T, M. canettii CIP140060001
T, M. pinnipedii
ATCC BAA-688, and M. caprae CIP105776
T reference strains
were purchased from the Collection Institut Pasteur (CIP, Paris,
France) and American Type Culture Collection (ATCC, Rock-
ville, USA). The following non-tuberculosis mycobacteria were
tested in order to assess the specificity of ETR-D spacer
sequencing: Mycobacterium avium IWGMT49
T, Mycobacterium
intracellulare CIP104243





T, Mycobacterium ulcerans CIP105425
T, Mycobacterium
xenopi CIP104035
T, Mycobacterium abscessus CIP104536
T, Myco-
bacterium chelonae CIP104535
T, Mycobacterium fortuitum ATCC49404
and Mycobacterium mucogenicum CIP 105223
T. Quality of DNA was
controlled by parallel partial rpoB PCR amplification as previously
described [42]. One hundred and ten MTC clinical isolates
(Table 1) recovered from Microbiology Laboratory in Marseille
(n=102), from Institut Pasteur in Djibouti (n=3) and from Institut
de Pharmacologie et Biologie Structurale, Toulouse (n=5) were
also analyzed. All isolates were identified as members of the MTC
by phenotypic characterization and a gene probe assay according
to the manufacturer (AccuProbe; Gene Probe Inc, San Diego,
Calif). This study was approved by the ethics committee of the
Institut Fe ´fe ´ratif de Recherche 48, Marseilles, France.
Phenotypic identification
Phenotypic characterisation included colony morphology, a
urease test controlled after 3 and 18 hour incubation, and oxygen
consumption measured after inoculation of a 0.2 ml actively
growing mycobacterial suspension into 40 ml of Middlebrook
7H10 into the Bactec 9000MB system (Becton and Dickinson, Le
Pont de la Claix, France) after a 3-week incubation. Drug
susceptibility tests for thiophene-2-carboxylic acid hydrazide
(TCH) and PZA were performed as previously described [43].
Reference tests for molecular identification
The identification of reference strains and clinical isolates
identified as M. bovis BCG type, M. canettii and M. africanum by
ETR-D sequencing (see below) was confirmed by parallel reference
molecular tests. Every isolate coated on beads was inactivated as
previously described [44] and the DNA was extracted using a
Qiagen kit (Qiagen, Courtaboeuf, France). DNA was used as a
template for PCR amplification of pncA, oxyR, hsp65, gyrB genes and
sequence analysis of MPTR was performed as previously described
[28,29,32–34,45] In addition, we sequenced the Rv0927c-pstS3
intergenic region in all clinical isolates identified as M. tuberculosis in
order to identify the Beijing genotype [46]. Amplified products were
visualized by agarose gel electrophoresis and direct sequencing was
performed as described above. Sequences were edited using the
Auto assembler program (Applied Biosystems, Courtaboeuf,
France) and aligned using CLUSTAL W (http://pbil.ibcp.fr).
Original sequences were deposited into GenBank (http://www.
ncbi.nlm.nih.gov/sites/entrez/).
ETR-D spacer sequencing
Amplification and sequencing of the ETR-D spacer located
between the putative histidine kinase Senx3 upstream and the
sensory transduction protein Regx3 downstream were done using
direct primers: 59-GTTGATCGAGGCCTATCACG-39 and 59-
GAATAGGGCTTGGTCACGTA-39. The PCR mixture con-
Figure 2. Distribution of Mycobacterium tuberculosis complex species in human tuberculosis cases in Africa. Based on a review of papers
published in 1999–2007 [22,64–70]. For each country, prevalence rates and reference are indicated in cartoons. Mtub, M. tuberculosis; M afr, M.
africanum; Mbov, M. bovis; Mcan, M. canettii; MTC, Mycobacterium tuberculosis complex.
doi:10.1371/journal.pntd.0000253.g002
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5 ml1 0 6 dDNTP, 1 ml forward primer, 1 ml reverse primer,
0.25 ml hotstart Taq (Qiagen) and 2 ml target DNA. Appropriate
negative controls consisting of PCR mix without target DNA were
also included. PCRs were performed using the following program:
15 min enzyme activation at 95uC, followed by 34 cycles
consisting of 95uC for 30 s, 58uC for 30 s, 72uC for 1 min,
followed by a 5 min elongation step at 72uC. After agarose gel
electrophoresis, PCR products were purified and subjected to
sequencing in both directions by using the BigDye Terminator 1.1
Cycle Sequencing kit (Applied Biosystems). Sequencing electro-
phoresis was performed on a 3130 genetic analyzer (Applied
Biosystems). The sequences were edited using the Auto assembler
program (Applied Biosystems) and aligned using CLUSTAL W
(http://pbil.ibcp.fr). Original ETR-D sequences were deposited
into Genbank (http://www.ncbi.nlm.nih.gov/sites/entrez/).
Results
Phenotypic identification (Table 2)
As for reference strains, M. tuberculosis exhibited eugonic growth
that was inhibited by the presence of PZA but not by TCH and
showed aerophilic growth on Middlebrook agar positive urease at
18 hours. M. bovis and M. bovis BCG type strains exhibited
microaerophilic dysgonic growth, did not grow in the presence of
TCH, but were resistant to PZA and exhibited a positive urease
activity at 3 hours for M. bovis BCG type and at 18 hours for M.
bovis. M. africanum type I differed from M. bovis by its susceptibility
to PZA. M. canettii exhibited eugonic growth in the presence of
PZA and TCH, and showed a positive urease activity at 3 hours
and aerophilic growth on Middlebrook. M. microti, M. capare and
M. pinnipedii exhibited eugonic growth that was inhibited by TCH
and PZA, and a positive urease at 18 hours. As for clinical isolates,
101/110 of isolates were phenotypically identified as M. tuberculosis,
5a sM. canettii,3a sM. bovis BCG type and one as M. africanum.
Reference molecular identification (Table 3)
In all PCR experiments, negative controls remained negative.
All reference strains and clinical isolates yielded an amplicon of the
expected size when amplified for pncA, oxyR, hsp65, gyrB genes,
Rv0927c-pstS3 intergenic region and MPTR. By comparison with
M. tuberculosis, the 410-bp oxyR gene sequence exhibited a
previously known A285G polymorphism in M. bovis and M. bovis
BCG type [29] and a newly identified T136G polymorphism in M.
canettii. The 561-bp pncA gene sequence exhibited a previously
known G253C polymorphism in M. bovis and M. bovis BCG type
[28] and a G222A polymorphism in M. canettii [47]. The 441-bp
hsp65 gene exhibited a previously known T235C polymorphism in
M. canettii [45] and a newly identified G376C polymorphism in M.
africanum type I. The 1.020-bp gyrB gene sequence exhibited an
identical sequence in M. tuberculosis, M. canettii and M. caprae,a
previously known A756G polymorphism in M. bovis and M. bovis
BCG type, a T675C polymorphism in M. microti, and an identical
sequence was identified in common with M. africanum type I and
M. pinnipedii [34]. Sequence analysis of MPTR (300-bp) exhibited a
unique sequence for M. tuberculosis (Sequevar Long), M. africanum
type I strain (Sequevar Short), M. bovis and M. microti (Sequevar
MED-G) and M. bovis BCG type (Sequevar MED-C) [32]; MPTR
sequencing newly identified C99T, G164C and A267G polymor-
phisms in M. canettii; the M. caprae strain exhibited Sequevar Long
in common with M. pinnipedii and M. tuberculosis reference strains.
Original sequences found in this study were deposited in GenBank
under the following accession numbers (GenBank: EF656461, EF
656463, EF 656464).
Sequence analysis of clinical isolates using the five previous
targets yielded four different profiles. One profile comprised 98
isolates identified as M. tuberculosis, including three isolates
identified as W-Beijing strains using a G127A polymorphism in
Rv0927c-pstS3 intergenic region, a second profile comprised five
isolates identified as M. bovis BCG type; a third profile included
five isolates identified as M. canettii and a fourth profile included
two isolates identified as M. africanum type I.
ETR-D sequence analysis
For all ETR-D experiments, negative controls remained
negative. All the non-tuberculosis mycobacteria yielded a negative
ETR-D PCR amplification whereas they yielded an amplicon of
the expected size through rpoB PCR amplification. The size of
PCR products obtained with MTC reference strains varied from
497-bp for M. canettii, 545-bp for M. bovis, 564-bp for M. caprae,
598-bp for M. bovis BCG type, 651-bp for M. africanum type I, 805-
bp for M. tuberculosis and 959-bp for M. microti and M. pinnipedii.
Each of the eight reference strains exhibited a unique ETR-D
sequence, exhibiting one to seven copies of a tandem repeat, six
mutations and two deletions/insertions.
M. tuberculosis exhibited three different alleles combining two or
five copies of a 77-bp repeat unit and one T/G SNP at the fifth
base of the tandem repeat, in addition to one 53-bp repeat unit.
The M. tuberculosis reference strain exhibited five copies of a 77-bp
repeat unit followed by one 53-bp repeat unit copy; M. microti and
M. pinnipedii exhibited seven copies of a 77-bp repeat unit and one
53-bp repeat unit, M. africanum type I exhibited three copies of a
77-bp repeat unit and one 53-bp repeat unit, in addition to one T/
C polymorphism at position 75. M. bovis exhibited four copies of a
77-bp repeat unit and one 53-bp repeat unit in addition to an A/G
SNP at position 773; M. bovis BCG type exhibited three copies of a
77-bp repeat unit in addition to an A/G SNP at position 773. M.
caprae exhibited three copies of a 77-bp repeat unit, a 34-bp
deletion and one 53-bp repeat unit. M. canettii exhibited one copy
of a 77-bp repeat unit and three SNPs following the tandem repeat
in addition to a 53-bp repeat unit. ETR-D sequences of MTC type
strains were deposited in GenBank under the following accession
numbers (GenBank: EU180228-EU180234). ETR-D sequencing
Table 1. Origin of Mycobacterium tuberculosis complex
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45 isolates presenting allele 1, 26 isolates presenting allele 2, and
27 isolates presenting allele 3; the ETR-D allele did not correlate
with Beijing genotype (P=0.2). 5/110 isolates were identified as
M. bovis BCG type, 5/110 isolates as M. canettii, and 2/110 isolates
as M. africanum type I. All unique ETR-D sequences were
deposited into our freely available database at http://ifr48.
timone.univ-mrs.fr/MST_Mtuberculosis/mst.
Comparison between ETR-D identification and reference
phenotypic and molecular identifications of clinical
isolates
ETR-D identification was in agreement with phenotypic
identification in 107/110 (97.27%) of clinical isolates. Three
isolates phenotypically identified as M. tuberculosis were identified
by ETR-D sequencing and reference molecular methods as M.
bovis BCG type in two cases and M. africanum type I in one case.
Reference molecular identification agreed with ETR-D identifi-
cation in 100% (110/110) of clinical isolates.
Discussion
Previous methods for MTC species identification either
combined the amplification of several genomic regions in order
to identify all species [27,48] or analyzed one gene polymorphism
to distinguish between only two species. ETR-D spacer sequencing
herein developed proved to be specific for the MTC and allowed
the differentiation of the 7/8 MTC species in a single reaction.
Indeed all the non-tuberculosis mycobacteria yielded a negative
ETR-D PCR amplification as previously described [49].
The fact that M. africanum type II was not included in the
present study may not modify this conclusion. In fact, the
taxonomic status of M. africanum type II has been disputed [50],
but it is now regarded as a phenotypic variant of M. tuberculosis
(genotype Uganda) [51,52]. ETR-D sequencing agreed in all cases
Table 2. Biochemical and antibiotic susceptibility profiles observed for M. tuberculosis complex reference strains and clinical














M. tuberculosis CIP103471 Eugonic - + S R Aerophilic
M. bovis CIP105050 Dysgonic - + R S Microaerophilic
M. bovis BCG type 105060 Dysgonic ++ R S Microaerophilic
M. africanum
T CIP105147 Dysgonic - + S S Microaerophilic
M. canettii
T CIP140060001 Eugonic ++ R R Aerophilic
M. caprae
T CIP105776 Eugonic - + S S Aerophilic
M. microti
T CIP104256 Eugonic - + S S Aerophilic
M. pinnipedii ATCC BAA-688 Eugonic - + S S Aerophilic
Clinical isolates
101 Eugonic - + S R Aerophilic
1 Dysgonic - + S S Microaerophilic
3 Dysgonic ++ R S Microaerophilic
5 Eugonic ++ R R Aerophilic
T: type strain, +: positive results, -: negative results, R: drug resistant, S: drug susceptible, TCH: thiophene-2-carboxylic acid hydrazide (5 mg/ml), PZA: pyrazinamide
(50 mg/ml).
doi:10.1371/journal.pntd.0000253.t002
Table 3. Single nucleotide polymorphisms in five housekeeping genes and MPTR sequence analysis in eight MTC reference strains
Strains oxyR pncA hsp65 gyrB MPTR
136 285 222 253 235 376 675 756 Sequence 99 164 267 Sequence
M. tuberculosis C I P 1 0 3 4 7 1 GGACCCCG TCGL o n g
M. africanum
T CIP105147 G G A C C G* C G sequevar T C G Short
M. bovis B C G t y p e 1 0 5 0 6 0 GAAGCCCA TCGMED-G
M. bovis CIP105050 G A A G CCCA TCGMED-G
M. canettii
T CIP140060001 T* G G C T C C G C* G* A* Long
M. microti
T CIP104256 G G A C C C T G sequevar T C G MED-G
M. pinnipedii A T C C 6 8 8 GGACCCCGs e q u evar T C G Long
M. caprae
T CIP105776 G G A C CCCG TCGL o n g
T: type strain,
*: Polymorphism identified newly in this study.
doi:10.1371/journal.pntd.0000253.t003
MTC Identification
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mutations were identified because some genes were sequenced
for the first time in some MTC species including the oxyR gene and
MPTR in M. canettii and the hsp65 gene in M. africanum type I
(Table 3). ETR-D sequencing revealed that 3/110 clinical isolates
identified as M. tuberculosis by phenotypic tests comprised two M.
bovis BCG type isolate and one M. africanum type I isolate. The
497-959-bp size of ETR-D allows one-step sequencing using a
modern capillary sequencer and software and may be easily
sequenced using Pyrosequencing and additional internal primers.
Cost was decreased in comparison with the current polyphasic
approach and any microbiologist could compare the ETR-D
sequence with those that we deposited in the versatile, freely
accessible databank at http://ifr48.timone.univ-mrs.fr/MST_
MTuberculosis/mst. This identification technique, based on
PCR amplification, could be directly applied to clinical specimens
exhibiting acid-fast bacilli.
ETR-D sequence identification relied not only on the variation
in the number of tandem repeats illustrated by various PCR
product sizes, as previously described [39] for M. tuberculosis, M.
africanum, M. bovis group [41], but also on specific SNPs, which are
stable events [53] accounting for 55.5% of genetic events observed
in this study and on insertion/deletion events (accounting for
22.2% of genetic events). However, the ETR-D sequence was not
correlated with the Beijing genotype as defined by Rv0927c-pstS3
intergenic region sequencing. This indicates that, although 3
ETR-D genotypes were found among M. tuberculosis isolates in this
study, ETR-D sequencing alone cannot be used for genotyping. It
is not surprising that the same, limited genomic region does not
have the potential to identify at the species and strain levels. ETR-
D sequencing provides, for the first time, a unique sequencing test
capable of distinguishing all MTC species in a single step.
Accurate identification of MTC isolates at the species level is of
particular interest in Africa where species other than M. tuberculosis
were characterized in human tuberculosis and M. bovis remains a
huge problem for cattle [21] (Figure 2). Their identification may
direct specific epidemiological investigation. In Africa, the
prevalence of M. bovis in human tuberculosis was correlated with
the prevalence in the local cattle population [54]. Consumption of
unpasteurised milk and of poorly heat-treated meat, and close
contact with infected animals represent the main sources of
infection for humans [3]. However, human to human transmission
of M. bovis was recently reported in a 6-case cluster including one
death due to M. bovis meningitis in United-Kingdom [17]. In
addition, the emergence of MDR M. bovis has been documented,
raising infection control in health care settings [55,56]. M. bovis
BCG type derived from the closely related virulent M. bovis after
230 serial passages had led to a considerably increased rate of
disseminated BCG disease in HIV-infected infants reported in
South Africa [57], although diagnoses were based on a few
biochemical tests including the urease test and RD1deletion [58].
ETR-D sequencing allows unambiguous distinguishing of BCG
type strains from M. bovis strains using a minute quantity of starting
material. M. africanum identification indicated a tuberculosis
microepidemic in a defined area when repeated isolation was
observed [59]. Sporadic isolation of M. africanum strains has been
reported in Europe and the United States, including outbreaks of
multidrug-resistant (MDR) strains [60,61]. In recent studies,
variations in the reported prevalence of M. africanum among
various African countries may also reflect difficulties in accurate
identification of this species (Figure 2). M. microti, M. pinnipedii, M.
caprae and M. canettii remain difficult to identify because of the
extremely slow growth of these organisms, the difficulties with
their identification under traditional bacteriological methods [62]
and the fact that these recently described species have not been
incorporated into current molecular identification schemes.
ETR-D spacer sequencing offers a new tool for the rapid and
accurate identification of all MTC species in a single sequencing
reaction without the need for expensive, time-consuming and
potentially harmful polyphasic approaches. Its use could assist
public health interventions and aid in the control of zoonotic
transmission in African countries. Accurate identification of MTC
isolates from Africa and tropical Asia would be of particular
interest from the perspective of the current emergence of
multidrug resistant and extended resistance isolates in these
countries [63].
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